This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 5 from Patent US 20100279918
General Information
DRACP ID DRACP01308
Peptide Name Sequence 5 from Patent US 20100279918
Sequence DAATATRGRSAASRPTERPRAPARSASRPRRVD
Sequence Length 33
UniProt ID Not available
PubChem CID Not available
Origin Herpes simplex virus type
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C142H248N60O47
Absent amino acids CFHIKLMNQWY
Common amino acids R
Mass 411883
Pl 12.6
Basic residues 9
Acidic residues 3
Hydrophobic residues 9
Net charge 6
Boman Index -16038
Hydrophobicity -134.85
Aliphatic Index 33.03
Half Life
Mammalian: 1.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 8
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2010/0279918 A1
Patent Title Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents.
Other Iinformation Granted Patent Family: 7s / 7ex; Family Jurisdictions: DE, EP, WO, AT, US; Legal Status: Discontinued; Application No: 22536707; Filed:Mar 20, 2007; Published: Nov 4, 2010; Earliest Priority: Mar 20, 2006;
Other Published ID DE602007011901D1 EP1991586A1 EP1991586B1 WO2007108749A1 WO2007108749A8
This work is licensed under a Creative Commons Attribution 4.0 International License.